Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. It is administered by sub-cutaneous injection and has been advertised as a way to slow the advance of the affliction as well as reduce the frequency of attacks... Wikipedia
Manufacturer's Website: Betaseron Average retail cost: $6,790/dose
Search Terms: Betaseron, interferon beta-1b, multiple sclerosis, MS